Champions Oncology, Inc. (CSBR)Healthcare | Biotechnology | Hackensack, United States | NasdaqCM
4.70 USD
-0.09
(-1.879%) ⇩
(Oct. 16, 2026, 4 p.m.
EDT)
|
Hot Take ↕ | Oct. 10, 2026, 10:51 a.m. EDT
The immediate outlook remains precarious due to a severe liquidity crisis. Trading volume has collapsed to less than 17% of the average, creating a high-risk environment where even minor selling pressure can cause disproportionate price drops. While the company recently reported record revenue growth and a turnaround in profitability, the market is pricing in a potential delisting or bankruptcy scenario rather than a standard biotech recovery story. The balance sheet is fragile, with debt significantly exceeding cash reserves, and the stock trades at a premium to book value despite negative historical returns on equity. On the long-term horizon, the multi-year price trajectory shows a massive cumulative gain, suggesting the market eventually rewarded the business's quality, but the current operational distress and lack of analyst coverage create a steep path to recovery. There is no dividend income to offset these risks. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.046951 |
| AutoETS | 0.049182 |
| AutoARIMA | 0.049358 |
| MSTL | 0.051830 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 32% |
| H-stat | 1.95 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.000 |
| Excess Kurtosis | 2.21 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 245.964 |
| Revenue per Share | 4.377 |
| Market Cap | 65,417,272 |
| Forward P/E | 47.00 |
| Beta | 0.44 |
| Profit Margins | -1.87% |
| Website | https://www.championsoncology.com |
As of Oct. 10, 2026, 10:51 a.m. EDT: Speculators are heavily positioned for downside protection, with significant open interest in out-of-the-money puts expiring in October and November at strikes well below the current price. Conversely, call activity is sparse and concentrated entirely at the money, indicating a lack of aggressive bullish speculation despite the recent price recovery.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.2664625 |
| Address1 | One University Plaza |
| Address2 | Suite 307 |
| All Time High | 25.8 |
| All Time Low | 1.11 |
| Ask | 6.45 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 9,000 |
| Average Daily Volume3 Month | 10,952 |
| Average Volume | 10,952 |
| Average Volume10Days | 9,000 |
| Beta | 0.438 |
| Bid | 3.53 |
| Bid Size | 2 |
| Book Value | 0.28 |
| City | Hackensack |
| Compensation As Of Epoch Date | 1,798,675,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 4.7 |
| Current Ratio | 1.03 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 4.835 |
| Day Low | 4.7 |
| Debt To Equity | 245.964 |
| Display Name | Champions Oncology |
| Dividend Yield | 0.0 |
| Earnings Call Timestamp End | 1,789,072,200 |
| Earnings Call Timestamp Start | 1,789,072,200 |
| Earnings Timestamp | 1,789,070,400 |
| Earnings Timestamp End | 1,789,070,400 |
| Earnings Timestamp Start | 1,789,070,400 |
| Ebitda | 402,000 |
| Ebitda Margins | 0.0066299997 |
| Enterprise To Ebitda | 180.588 |
| Enterprise To Revenue | 1.197 |
| Enterprise Value | 72,596,272 |
| Eps Forward | 0.1 |
| Eps Trailing Twelve Months | -0.07 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 5.013 |
| Fifty Day Average Change | -0.3130002 |
| Fifty Day Average Change Percent | -0.062437702 |
| Fifty Two Week Change Percent | -26.64625 |
| Fifty Two Week High | 8.31 |
| Fifty Two Week High Change | -3.6100006 |
| Fifty Two Week High Change Percent | -0.4344164 |
| Fifty Two Week Low | 4.59 |
| Fifty Two Week Low Change | 0.10999966 |
| Fifty Two Week Low Change Percent | 0.023965066 |
| Fifty Two Week Range | 4.59 - 8.31 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,170,426,600,000 |
| Float Shares | 6,108,303 |
| Forward Eps | 0.1 |
| Forward P E | 46.999996 |
| Free Cashflow | -5,487,875 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 214 |
| Fullday Change | -0.09000015 |
| Fullday Change Percent | -1.8789176 |
| Fullday Price | 4.7 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.49822 |
| Gross Profits | 30,223,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.26332 |
| Held Percent Institutions | 0.48708 |
| Implied Shares Outstanding | 13,918,569 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,777,507,200 |
| Last Split Date | 1,439,337,600 |
| Last Split Factor | 1:12 |
| Long Business Summary | Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice through TumorGraft Technology Platform. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceutical and biotechnology companies. In addition, the company offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. It markets its products through internet and sales force to pharmaceutical and biotechnology companies. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey. |
| Long Name | Champions Oncology, Inc. |
| Market | us_market |
| Market Cap | 65,417,272 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_323655 |
| Most Recent Quarter | 1,785,456,000 |
| Net Income To Common | -1,135,000 |
| Next Fiscal Year End | 1,809,043,200 |
| Non Diluted Market Cap | 69,871,216 |
| Open | 4.835 |
| Operating Cashflow | -5,564,000 |
| Operating Margins | -0.02685 |
| Payout Ratio | 0.0 |
| Phone | 201 808 8400 |
| Previous Close | 4.79 |
| Price Hint | 4 |
| Price To Book | 16.785713 |
| Price To Sales Trailing12 Months | 1.0783896 |
| Profit Margins | -0.01871 |
| Quick Ratio | 0.959 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.09000015 |
| Regular Market Change Percent | -1.8789176 |
| Regular Market Day High | 4.835 |
| Regular Market Day Low | 4.7 |
| Regular Market Day Range | 4.7 - 4.835 |
| Regular Market Open | 4.835 |
| Regular Market Previous Close | 4.79 |
| Regular Market Price | 4.7 |
| Regular Market Time | 1,792,180,800 |
| Regular Market Volume | 1,843 |
| Return On Assets | -0.018229999 |
| Return On Equity | -0.28382 |
| Revenue Growth | 0.088 |
| Revenue Per Share | 4.377 |
| Sand P52 Week Change | 0.16207206 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 13,918,569 |
| Shares Percent Shares Out | 0.0050999997 |
| Shares Short | 70,961 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 74,290 |
| Short Name | Champions Oncology, Inc. |
| Short Percent Of Float | 0.0104 |
| Short Ratio | 4.95 |
| Source Interval | 15 |
| State | NJ |
| Symbol | CSBR |
| Total Cash | 4,358,000 |
| Total Cash Per Share | 0.313 |
| Total Debt | 10,970,000 |
| Total Revenue | 60,662,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.07 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 5.85595 |
| Two Hundred Day Average Change | -1.1559501 |
| Two Hundred Day Average Change Percent | -0.19739753 |
| Type Disp | Equity |
| Volume | 1,843 |
| Website | https://www.championsoncology.com |
| Zip | 7,601 |